Afuco™ Anti-Human ANGPTL4 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-ANGPTL4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a fully human antibody specifically binds and inhibits or interferes with at least one activity of human angiopoietin-like protein 3 (hANGPTL3). The human anti-hANGPTL3 antibodies are useful in treating diseases or disorders associated with ANGPTL3, such as hyperlipidemia, hyperlipoproteinemia and dyslipidemia, including hypertriglyceridemia, hypercholesterolemia, chylomicronemia, and so forth.
Supplier Creative Biolabs
Product # AFC-038CL
Pricing Inquiry
Host Human
Target ANGPTL4
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage.
Feedback